Quantcast

Latest Nosology Stories

2012-01-15 13:00:00

Complete Medical Solutions´ Dennis Flint leads the educational charge as firm teams with MedLearn on critical General Equivalence Mappings software translator. Baton Rouge, Louisiana (PRWEB) January 15, 2012 Dennis Flint is working hard now to make sure America´s healthcare providers are ready for the massive changes coming next year to the nation´s medical diagnosis coding system. The Center for Medicare & Medicaid Studies´ planned update from ICD-9 to ICD-10 in...

2011-05-05 05:00:00

SAN DIEGO, May 5, 2011 /PRNewswire/ -- Ridge Diagnostics, Inc., a neurodiagnostic company, announced that Lonna J. Williams, CEO will speak at the 6th Annual Neurotech Investing and Partnering Conference to be held in San Francisco, CA at the St. Regis Hotel on May 9th and 10th. Ms. Williams, a clinical diagnostics industry veteran, will participate on a panel entitled "Next Generation Psychiatry" lead by Dr. Manuel Lopez-Figueroa, Vice President, Bay City Capital. The panel will discuss...

2010-10-12 08:00:00

ALBUQUERQUE, N.M., Oct. 12 /PRNewswire/ -- Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, today announced the purchase of Cypress Bioscience, Inc.'s diagnostic business, located in San Diego, Calif. Under the terms of the agreement, Exagen will purchase the diagnostic business in its entirety, including all testing services, intellectual property rights and equipment. Exagen has offered employment to all Cypress...

2010-10-04 07:30:00

BASEL, Switzerland/>, Oct. 4/> /PRNewswire-FirstCall/ - Neuro-Biotech Corporation (PINKSHEET: MRES)(OTCQB:MRES) Pursuant to the company's press release issued the 30th of September 2010/>, the following is a brief review and explanation of the earlier statements concerning the first of many Neuro-Biotech's licensed products, "SymPath(R) blood test". For a better understanding, an "in vitro" blood test is described as, a non evasive test, whereas the testing, as in the case of...

2010-09-14 23:48:17

Silvia Mamede, M.D., Ph.D., of Erasmus University Rotterdam, the Netherlands and colleagues investigated whether recent experience with clinical problems provokes availability bias (overestimation of the likelihood of a diagnosis based on the ease with which it comes to mind) resulting in diagnostic errors and whether reflection (structured reanalysis of the case findings) counteracts this bias. The researchers conducted a study in 2009 with 18 first-year and 18 second-year internal medicine...

2010-03-02 08:56:50

Researchers led by Philip Fernbach, a cognitive and linguistic sciences graduate student, have found that individuals are more likely to consider alternative causes when they make diagnoses than when they make decisions about the future. The findings suggest that framing problems as diagnostic-likelihood judgments can reduce bias. Details will be in the March 2010 edition of Psychological Science. PROVIDENCE, R.I. -- Brown University researchers have identified a way to improve thought...

2009-04-14 13:00:00

SAN DIEGO, April 14 /PRNewswire/ -- XIFIN Inc., the leading provider of revenue cycle management for diagnostic laboratories, announced today that XIFIN's CEO and Executive Chairman, Lale White, will speak at the Executive War College Conference in New Orleans on April 28th 2009. In attendance will be senior executives, laboratory administrators and pathologists from many of the nation's largest laboratory organizations. (Logo: http://www.newscom.com/cgi-bin/prnh/20081013/LAM046LOGO) The...

2008-10-07 09:00:55

SALT LAKE CITY, Oct. 7 /PRNewswire/ -- Great Basin Scientific, Inc., a privately held life sciences company developing novel, point-of-care molecular diagnostic solutions, today announced it had closed a $3.9 million financing round. New and returning investors participated in the funding for this round. The new round of financing will fund the company through the spring of 2009 as it completes the design of its rapid molecular diagnostic testing platform and brings a...

2008-09-04 09:00:48

SUNNYVALE, Calif., Sept. 4 /PRNewswire/ -- Pathwork Diagnostics, a molecular diagnostics company focused on oncology, announced the closing today of a $20 million financing led by Abingworth. The announcement came on the heels of FDA's clearance for the Pathwork(R) Tissue of Origin Test for diagnosis of tumors of uncertain origin, including poorly differentiated, undifferentiated and metastatic tumors. "With this $20 million round of financing completed and the recent FDA clearance, the...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related